Histone deacetylase inhibitors exert anti-tumor effects on human adherent and stem-like glioma cells

BACKGROUND: The diagnosis of glioblastoma (GBM), a most aggressive primary brain tumor with a median survival of 14.6 months, carries a dismal prognosis. GBMs are characterized by numerous genetic and epigenetic alterations, affecting patient survival and treatment response. Epigenetic mechanisms ar...

Descripción completa

Detalles Bibliográficos
Autores principales: Was, Halina, Krol, Sylwia K., Rotili, Dante, Mai, Antonello, Wojtas, Bartosz, Kaminska, Bozena, Maleszewska, Marta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6337817/
https://www.ncbi.nlm.nih.gov/pubmed/30654849
http://dx.doi.org/10.1186/s13148-018-0598-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6337817/
https://www.ncbi.nlm.nih.gov/pubmed/30654849
http://dx.doi.org/10.1186/s13148-018-0598-5

Ejemplares similares